Fluorescence in situ hybridization in cervical smears: detection of numerical aberrations of chromosomes 7, 3, and X and relationship to HPV infection.

BACKGROUND Human papillomavirus (HPV) is known to play a pivotal role in cervical carcinogenesis. Chromosomal aberrations are known to be related to different biological behaviors of malignant lesions. We analyzed whether numerical chromosomal aberrations, related to more aggressive tumor types, are found not only in high-grade squamous intraepithelial lesions (HSIL) but also in low-grade SIL (LSIL) of the cervix and evaluated their relationship to HPV infection. METHODS Eighty women (19 to 74 years of age) were included in this study and grouped according to the Bethesda System: within normal limits (WNL), LSIL, and HSIL. By FISH, chromosomes 7 and X, and in part chromosome 3, were analyzed for numerical aberrations. Using the hybrid capture system HPV detection was performed. RESULTS All 20 patients with cervical smear WNL had regular diploid chromosomal pattern and were negative for HPV. Thirteen of the 29 (41.2%) patients with LSIL showed trisomy 7, in association with trisomy X in 4 cases (12.9%). Single trisomy X was detected in 4 cases (12.9%). In 3 of 15 (20%) cases analyzed for chromosome 3 trisomy was observed. Trisomy 3 was associated with trisomy 7 and X or with trisomy 7 alone. The hybrid capture test was performed in 16 patients of this group. Two patients were positive for HPV probe A, 9 for probe B, and 2 for A and B, and 3 patients were negative. Twenty-three of the 29 patients (79.3%) with HSIL showed trisomy 7. Twelve of the 29 patients (41.3%) had an additional trisomy X. Single trisomy X was seen in only 2 cases (6. 9%). Twenty-two patients with HSIL were tested also for chromosome 3. Nine of the 22 patients (40.9%) showed trisomy 3, associated with trisomy 7 or with trisomy 7 and X. In 25 of the 29 patients HPV detection by the hybrid capture system was performed. HPV probe B was positive in 15 cases (60%). One patient was positive for both probes, A and B. Nine (36%) of the patients with HSIL were negative for both HPV probes. No positivity was observed for HPV probe A alone. CONCLUSION Our data confirm the pivotal role of HPV in cervical carcinogenesis as it seems to cause changes in the chromosomal pattern of premalignant lesions. Additionally, trisomy 7 may be considered an early event in cervical carcinogenesis, persisting and increasing with progression of the lesion. The roles of trisomy 3 and X need further evaluation.

[1]  W. Sauerbrei,et al.  Human papillomavirus DNA in cervical carcinoma—correlation with clinical data and influence on prognosis , 1994, International journal of cancer.

[2]  F. X. Bosch,et al.  The role of HPV in the etiology of cervical cancer. , 1994, Mutation research.

[3]  M. Fox,et al.  Chromosome changes in 43 carcinomas of the cervix uteri. , 1990, Cancer genetics and cytogenetics.

[4]  C. Griffin,et al.  Cytogenetic and FISH analysis of endometrial carcinoma. , 1994, Cancer genetics and cytogenetics.

[5]  H. Klinger,et al.  Genomic alterations in cervical carcinoma: losses of chromosome heterozygosity and human papilloma virus tumor status. , 1996, Cancer research.

[6]  H. Höfler,et al.  Numerical abnormalities of chromosome 7 in human prostate cancer detected by fluorescence in situ hybridization (FISH) on paraffin‐embedded tissue sections with centromere‐specific dna probes , 1994, The Journal of pathology.

[7]  P. Troncoso,et al.  Trisomy 7: A potential cytogenetic marker of human prostate cancer progression , 1994, Genes, chromosomes & cancer.

[8]  M. Chan,et al.  Genetic lesion in the carcinogenesis of cervical cancer. , 1992, Anticancer research.

[9]  C. Mok,et al.  Presence of p53 mutation in human cervical carcinomas associated with HPV-33 infection. , 1992, Anticancer research.

[10]  P. Rabbitts,et al.  PCR‐RFLP studies on chromosome 3p in formaldehyde‐fixed, paraffin‐embedded cervical cancer tissues , 1994, International journal of cancer.

[11]  R. Chaganti,et al.  Allelotype analysis of cervical carcinoma. , 1994, Cancer research.

[12]  L. Meisner,et al.  Use of fluorescent in situ hybridization to detect aneuploidy in cervical dysplasia , 1996, Diagnostic cytopathology.

[13]  J. Arseneau,et al.  Human papillomavirus DNA in invasive cervical carcinomas and its association with patient survival: a nested case-control study. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[14]  C. Woodworth,et al.  Cellular and molecular alterations in human epithelial cells transformed by recombinant human papillomavirus DNA. , 1993, Critical reviews in oncogenesis.

[15]  M. Qumsiyeh,et al.  Numerical chromosome abnormalities associated with early clinical stages of gynecologic tumors. , 1991, Cancer genetics and cytogenetics.

[16]  B H Mayall,et al.  Centromeric copy number of chromosome 7 is strongly correlated with tumor grade and labeling index in human bladder cancer. , 1991, Cancer research.

[17]  J W Gray,et al.  Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[18]  C. Rygaard,et al.  Management of low-grade CIN: follow-up or treatment? , 1995, European journal of obstetrics, gynecology, and reproductive biology.

[19]  V. Abeler,et al.  Human papilloma virus has no prognostic significance in cervical carcinoma. , 1996, European journal of cancer.

[20]  Chi-An Chen,et al.  The genotypes and prognostic significance of human papillomaviruses in cervical cancer , 1994, International journal of cancer.

[21]  A. Lamhonwah,et al.  Mutations participating in interallelic complementation in propionic acidemia. , 1994, American journal of human genetics.

[22]  H. Klinger,et al.  Loss of heterozygosity on chromosome 17p and mutant p53 in HPV-negative cervical carcinomas , 1992, The Lancet.

[23]  Y. Taketani,et al.  Type of human papillomavirus is related to clinical features of cervical carcinoma , 1996, Cancer.

[24]  Diane Solomon,et al.  The Bethesda System for reporting cervical/vaginal cytologic diagnoses: revised after the second National Cancer Institute Workshop, April 29-30, 1991. , 1993, Acta cytologica.

[25]  J. Hofbauer,et al.  Fluorescence in situ hybridization identifies more aggressive types of primarily noninvasive (stage pTa) bladder cancer. , 1997, The Journal of urology.

[26]  A. Vecchione,et al.  p53 expression and genetic evidence for viral infection in intraepithelial neoplasia of the uterine cervix. , 1994, Gynecologic oncology.

[27]  K. Syrjänen,et al.  Spontaneous evolution of intraepithelial lesions according to the grade and type of the implicated human papillomavirus (HPV). , 1996, European journal of obstetrics, gynecology, and reproductive biology.